13 research outputs found
Comment on - Switching from vitamin K antagonist to dabigatran in atrial fibrillation:differences according to dose: reply
No full textShifting to a non-vitamin K antagonist oral anticoagulation agent from vitamin K antagonist in atrial fibrillation
No full textC-reactive protein after coronary artery bypass graft surgery and its relationship with postoperative atrial fibrillation
No full textThe importance of time in therapeutic range in switching from vitamin K antagonist to non-vitamin K antagonist oral anticoagulants in atrial fibrillation
No full textIncidence of ischaemic stroke and mortality in patients with acute coronary syndrome and first-time detected atrial fibrillation:a nationwide study
No full textOutcomes Among Patients With Atrial Fibrillation and Appropriate Anticoagulation Control
No full textSwitching from Vitamin K Antagonist to Dabigatran in Atrial Fibrillation:Differences According to Dose
No full textTime to Thrombolysis and Long-Term Outcomes in Patients With Acute Ischemic Stroke:A Nationwide Study
No full textTime trends in incidence, comorbidity, and mortality of ischemic stroke in Denmark (1996-2016)
No full text
